$IHT

WIRTH JAMES F sold $50K of IHT

WIRTH JAMES F (President & CEO) sold 43,111 shares of INNSUITES HOSPITALITY TRUST (IHT) at $1.17 on 2026-10-07 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · WIRTH JAMES F
Published Oct 10, 2026, 12:27 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 10, 2026, 12:31 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$IHT
Neutral
high confidence
Mentioned
$IHT
Relevance
2/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$IHTNeutralLow
01

Why it matters

The disclosed sale is small and pre‑arranged, so market impact is expected to be limited.

02

Market read

A routine insider sell with modest size; unlikely to drive significant price movement.

03

What to watch

The 10b5‑1 plan indicates the sale was pre‑scheduled, reducing the likelihood of new negative information.

Relevance 2/10Novelty 2/10Timing: post‑market filing on 2026‑10‑09

Background

Form 4 filings disclose insider transactions; investors monitor them for potential signals.

Company-level read

Ticker impact

$IHTNeutralHigh confidence
Context

President & CEO James Wirth sold 43,111 IHT shares for $50.4K via a 10b5‑1 plan on 2026‑10‑07.

Expected impact

likely slight pressure as the market prices the insider sell

Evidence & confidence

Small dollar amount relative to float and a pre‑arranged plan suggest no material information, but any insider sell can generate minor short‑term downside.

Market effects

Minimal; the REIT sector is not materially affected by a single small insider sale.

None

None

Counterpoint

If the sale signals undisclosed concerns, a short position could be considered.

Key entities

  • James Wirth

    President & CEO of InnSuites Hospitality Trust

  • InnSuites Hospitality Trust

    US‑listed REIT (ticker IHT) focused on hospitality assets

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$LYCAMedAI 8/10

Venrock Healthcare Capital Partners III, L.P. (Koh Bong Y, Shah Nimish P) purchased $37.7M of LYCA (indirect holdings)

Venrock Healthcare Capital Partners III, L.P. purchased 2,045,440 indirectly-held shares of Lycia Therapeutics, Inc. (LYCA) at an average of $18.41 ($18.00–$26.97, $37.65M total) across 6 trades over 2026-10-23 to 2026-10-27. Filed jointly with VHCP Co-Investment Holdings III, LLC (10% owner), VHCP Management III, LLC (10% owner), Venrock Healthcare Capital Partners EG, L.P. (10% owner), VHCP Management EG, LLC (10% owner), Venrock Healthcare Capital Partners XP, L.P. (10% owner), VHCP Management XP, LLC (10% owner), Koh Bong Y (10% owner) and Shah Nimish P (10% owner).